JPWO2022114058A1 - - Google Patents

Info

Publication number
JPWO2022114058A1
JPWO2022114058A1 JP2022565405A JP2022565405A JPWO2022114058A1 JP WO2022114058 A1 JPWO2022114058 A1 JP WO2022114058A1 JP 2022565405 A JP2022565405 A JP 2022565405A JP 2022565405 A JP2022565405 A JP 2022565405A JP WO2022114058 A1 JPWO2022114058 A1 JP WO2022114058A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022565405A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2022114058A1 publication Critical patent/JPWO2022114058A1/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2022565405A 2020-11-26 2021-11-25 Pending JPWO2022114058A1 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020195818 2020-11-26
PCT/JP2021/043186 WO2022114058A1 (ja) 2020-11-26 2021-11-25 肺線維症治療剤

Publications (1)

Publication Number Publication Date
JPWO2022114058A1 true JPWO2022114058A1 (ja) 2022-06-02

Family

ID=81754361

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022565405A Pending JPWO2022114058A1 (ja) 2020-11-26 2021-11-25

Country Status (6)

Country Link
US (1) US20240115586A1 (ja)
EP (1) EP4252756A1 (ja)
JP (1) JPWO2022114058A1 (ja)
CN (1) CN116710105A (ja)
TW (1) TW202237140A (ja)
WO (1) WO2022114058A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024117128A1 (ja) * 2022-11-29 2024-06-06 Ｓａｎｓｈｏ株式会社 眼圧下降剤、及び緑内障若しくは高眼圧症の治療剤又は予防剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3195833B2 (ja) 1991-09-30 2001-08-06 きみ子 室伏 新規生理活性物質及びその製造法
JPH07149772A (ja) 1993-11-26 1995-06-13 Sagami Chem Res Center タンパク質リン酸化酵素ｃの活性促進剤
JPH07258278A (ja) 1994-03-18 1995-10-09 Sagami Chem Res Center １−Ｏ−アシルグリセロール−２，３−ホスフェート誘導体を有効成分とするＤＮＡポリメラーゼαの阻害剤
JPH0925235A (ja) 1995-07-13 1997-01-28 Sagami Chem Res Center １−ｏ−アシルグリセロール−２，３−ホスフェート誘導体を有効成分とするがん転移抑制剤
JP2001178489A (ja) 1999-12-24 2001-07-03 Kimiko Murofushi 環状ホスファチジン酸の製造法
US20040214799A1 (en) 2001-05-21 2004-10-28 Mutsuko Mukai Cancerous metastasis inhibitors containing carbacyclic phosphatidic acid derivatives
JP4162927B2 (ja) 2002-06-11 2008-10-08 きみ子 室伏 カルバ環状ホスファチジン酸誘導体
JP2008208058A (ja) * 2007-02-26 2008-09-11 Nof Corp フォーカルアドヒージョン形成促進剤および、その用途
JP5737888B2 (ja) 2010-09-06 2015-06-17 Ｓａｎｓｈｏ株式会社 アトピー性皮膚炎治療剤
ES2634008T3 (es) 2011-11-11 2017-09-26 Sansho Co. Ltd. Agente terapéutico para la artrosis
WO2016024605A1 (ja) 2014-08-12 2016-02-18 大塚化学株式会社 環状ホスホン酸ナトリウム塩の結晶及びその製造方法

Also Published As

Publication number Publication date
WO2022114058A1 (ja) 2022-06-02
EP4252756A1 (en) 2023-10-04
US20240115586A1 (en) 2024-04-11
CN116710105A (zh) 2023-09-05
TW202237140A (zh) 2022-10-01

Similar Documents

Publication Publication Date Title
BR112023005462A2 (ja)
BR112021014123A2 (ja)
BR112023012656A2 (ja)
BR112022009896A2 (ja)
BR112022024743A2 (ja)
JPWO2022114058A1 (ja)
BR102021018859A2 (ja)
BR102021015500A2 (ja)
BR112023011738A2 (ja)
BR112023016292A2 (ja)
BR112023004146A2 (ja)
BR112023011610A2 (ja)
BR102021020147A2 (ja)
BR102021018926A2 (ja)
BR102021018167A2 (ja)
BR102021017576A2 (ja)
BR102021016837A2 (ja)
BR102021016551A2 (ja)
BR102021016375A2 (ja)
BR102021016176A2 (ja)
BR102021016200A2 (ja)
BR102021015566A2 (ja)
BR102021015450A8 (ja)
BR102021015220A2 (ja)
BR102021015247A2 (ja)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20230512